NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Akebia Therapeutics (NQ: AKBA)
8.030 USD  +0.250 (+3.21%)
Official Closing Price  /  Updated: 5:13 PM EST, Jan 17, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,766,100
Open 7.860
Bid (Size) 7.500 (10)
Ask (Size) 8.050 (3)
Prev. Close 7.780
Today's Range 7.840 - 8.080
52wk Range 2.990 - 9.300
Shares Outstanding 56,913,886
Dividend Yield N/A
Performance
YTD
+26.66%
+26.66%
1 Month
+28.89%
+28.89%
3 Month
+93.49%
+93.49%
6 Month
+112.43%
+112.43%
1 Year
+25.67%
+25.67%
Top News
More News
Akebia Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that its... Read More
from Business Wire News Releases
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted six newly-hired... Read More
from Business Wire News Releases
More News
Read More
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from Business Wire News Releases
We Did The Math XBI Can Go To $124
category ETFs
from ETF Channel
Akebia Therapeut Has Returned 57.5% Since SmarTrend Recommendation (AKBA)
from Comtex SmarTrend® News Briefs
Interesting AKBA Put And Call Options For February 2020
category Stocks
from Market News Video
Uptrend Call Working As Akebia Therapeut Stock Rises 45.2% (AKBA)
from Comtex SmarTrend® News Briefs
40.7% Return Seen to Date on SmarTrend Akebia Therapeut Call (AKBA)
from Comtex SmarTrend® News Briefs
Akebia Therapeut (AKBA)
from Comtex SmarTrend® News Briefs
Sum Up The Parts: VTWV Could Be Worth $122
category ETFs
from ETF Channel
Hedge Funds Had Impeccable Timing Buying Myovant Sciences Ltd. (MYOV)
category Stocks / Equities , Pharma/Biotech , Healthcare
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.